drugset / Trial / NCT03650608
A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of HL217 Eye Drop in Healthy Male Subjects
RandomizedSequentialTriple-blindBasic science
Summary
The purpose of this study is to evaluate the safety, tolerability and PK parameters in healthy subjects.
Timeline
- Start
- 2016-08
- Primary completion
- 2017-08
- Completion
- 2017-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HL217 | Unknown | 3 mg/ml | Other |
Indications
No indication recorded.